#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15950	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2125	746.1	0	.	n	.	0	C451T	SNP	451	451	C	754	754	T	940	T,C,A	483,408,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15950	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2125	746.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1487	1487	C	939	C,T	881,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28808	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3406	841.1	0	.	n	.	0	T695C	SNP	695	695	T	967	967	C	893	C,T	835,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28808	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3406	841.1	0	.	n	.	0	A1638G	SNP	1638	1638	A	1910	1910	G	871	G,A	597,216	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28808	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3406	841.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2243	2243	C	877	C,A,T	804,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28808	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3406	841.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2317	2317	A	910	A	868	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28808	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3406	841.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2869	2869	C	939	C	888	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2228	folP	855	855	100.0	folP.l15.c4.ctg.1	1558	142.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1027	1029	AGC	233;228;228	A;G;C	220;218;215	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6448	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3342	192.3	1	SNP	p	S91F	1	.	.	271	273	TTC	593	595	TTC	207;207;207	T;T;C	198;198;197	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6448	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3342	192.3	1	SNP	p	D95G	1	.	.	283	285	GGC	605	607	GGC	202;198;198	G;G;C	190;188;187	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6448	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3342	192.3	1	SNP	p	G95N	0	.	.	283	285	GGC	605	607	GGC	202;198;198	G;G;C	190;188;187	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1780	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1370	129.7	1	SNP	p	G45D	0	.	.	133	135	GGC	506	508	GGC	230;234;238	G;G;C	215;218;219	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	914	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1025	88.9	0	.	n	.	0	A197.	DEL	197	197	A	602	602	A	225	A	207	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6236	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2833	218.8	1	SNP	p	D86N	0	.	.	256	258	GAC	451	453	GAC	234;232;230	G;A;C	223;217;220	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6236	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2833	218.8	1	SNP	p	R87W	0	.	.	259	261	CGT	454	456	CGT	228;227;225	C;G;T	218;218;212	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6236	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2833	218.8	1	SNP	p	S87R	1	.	.	259	261	CGT	454	456	CGT	228;227;225	C;G;T	218;218;212	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6236	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2833	218.8	1	SNP	p	R87I	0	.	.	259	261	CGT	454	456	CGT	228;227;225	C;G;T	218;218;212	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6236	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2833	218.8	1	SNP	p	S88P	0	.	.	262	264	TCC	457	459	TCC	227;222;224	T;C;C	215;211;216	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4658	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2748	168.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1572	1574	GGC	233;232;236	G;G;C	219;219;220	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.35.001	penA.35.001	1	1	27	4190	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2264	183.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1220	1222	GCC	228;229;229	G;C;C,A	212;214;214,1	penA.35.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	4190	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2264	183.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1223	1225	ATG	226;225;226	A;T;G,C	212;211;213,1	penA.35.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	4190	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2264	183.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1235	1237	ACC	234;235;236	A,G;C,T,G;C,G	218,1;222,1,1;223,1	penA.35.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	4190	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2264	183.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1235	1237	ACC	234;235;236	A,G;C,T,G;C,G	218,1;222,1,1;223,1	penA.35.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	4190	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2264	183.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1736	1738	ACC	206;204;205	A;C;C	190;193;193	penA.35.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	4190	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2264	183.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1790	1792	GCG	205;208;205	G;C;G	168;164;168	penA.35.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	4190	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2264	183.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1790	1792	GCG	205;208;205	G;C;G	168;164;168	penA.35.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	4190	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2264	183.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1913	1915	GGT	176;176;176	G;G;T	161;163;161	penA.35.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	4190	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2264	183.9	1	SNP	p	G545S	0	.	.	1633	1635	GGC	1922	1924	GGC	172;171;170	G;GC,G;C	155;142,1;151	penA.35.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	4190	penA	1746	1746	100.0	penA.l6.c17.ctg.1	2264	183.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1940	1942	CCG	149;152;152	C,G;C;G	115,2;120;115	penA.35.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6164	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3323	185.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1758	1760	CCG	238;238;236	C;C;G	215;219;212	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2892	porA	1146	1146	99.91	porA.l15.c30.ctg.1	1859	154.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	519	519	C	188	C	174	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2954	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1704	172.9	0	.	p	.	0	I45V	NONSYN	133	135	ATT	481	483	GTT	226;225;222	G;T;T	217;211;212	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2954	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1704	172.9	1	SNP	p	G120K	1	.	.	358	360	AAG	706	708	AAG	251;245;246	A;A;G	235;235;231	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2954	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1704	172.9	1	SNP	p	A121N	1	.	.	361	363	AAC	709	711	AAC	241;240;244	A;A;C	228;228;233	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2954	porB1b	1038	1038	99.9	porB1b.l6.c4.ctg.1	1704	172.9	1	SNP	p	N121D	0	.	.	361	363	AAC	709	711	AAC	241;240;244	A;A;C	228;228;233	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11050	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4799	229.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1268	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	987	127.0	1	SNP	p	V57M	1	.	.	169	171	ATG	519	521	ATG	246;246;249	A;T;G	239;239;242	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
